search
Back to results

Indocyanine Green and Rectosigmoid Endometriosis (vincendo)

Primary Purpose

Endometriosis, Rectum, Bowel Endometriosis

Status
Unknown status
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
assessment of bowel symptoms before surgery
assessment of rectosigmoid during laparoscopy
follow up and assessment of bowel symptoms after surgery
assessment of rectosigmoid perfusion during robot-assisted laparoscopy
Sponsored by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Endometriosis, Rectum

Eligibility Criteria

18 Years - 45 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of deep endometriosis based on clinical and transvaginal/transabdominal ultrasound examinations and, when necessary, magnetic resonance
  • Patients with indication for removal of endometriosic lesions by laparoscopic surgery
  • Obtaining Informed Consent

Exclusion Criteria:

  • Known or suspected allergy to iodine
  • Previous rectal surgery
  • History of active pelvic infection
  • Intra-abdominal or pelvic malignancy
  • Pelvic radiation therapy
  • Hyperthyroidism
  • Liver dysfunction
  • Serum creatinine > 2.0 mg/dL

Sites / Locations

  • Gynecology and Physiopathology of Human Reproductive Unit, University of Bologna, S. Orsola-Malpighi HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

laparoscopic approach

robot-assisted approach

Arm Description

assessment of bowel symptoms before surgery; assessment of rectosigmoid perfusion using indocyanine green; removal of rectosigmoid endometriosis nodule using a laparoscopic approach; follow up and assessment of bowel symptoms after surgery

assessment of bowel symptoms before surgery; assessment of rectosigmoid perfusion using indocyanine green; removal of rectosigmoid endometriosis nodule using a robot-assisted approach; follow up and assessment of bowel symptoms after surgery

Outcomes

Primary Outcome Measures

correlation between bowel symptoms and rectosigmoid perfusion before the nodule removal
comparison between bowel symptoms, assessed through validated questionnaires (Knowles-Eccersley-Scott-Symptom Questionnaire and Gastrointestinal Quality of Life Index) and rectosigmoid perfusion, measured before the nodule removal using indocyanine green and a scale from 0 to 4.

Secondary Outcome Measures

correlation between bowel symptoms and rectosigmoid perfusion after the nodule removal
comparison between rectosigmoid perfusion, measured after the nodule removal using indocyanine green and a scale from 0 to 4, and bowel symptoms, assessed through validated questionnaires (Knowles-Eccersley-Scott-Symptom Questionnaire and Gastrointestinal Quality of Life Index).
correlation between bowel perfusion after rectal surgery and post-operative complications
assessment of rectosigmoid perfusion, through indocyanine green and a scale from 0 to 4, and complications (rectovaginal fistula, dehiscence of anastomotic suture, rectal bleeding, rectosigmoid perforation, rectosigmoid stenosis), using Clavien-Dindo Classification.

Full Information

First Posted
April 9, 2018
Last Updated
June 13, 2019
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
search

1. Study Identification

Unique Protocol Identification Number
NCT03532074
Brief Title
Indocyanine Green and Rectosigmoid Endometriosis
Acronym
vincendo
Official Title
Intraoperative Assessment of Bowel Perfusion Through Indocyanine Green in Women With Rectosigmoid Endometriosis and Its Correlation With Clinical and Surgical Data
Study Type
Interventional

2. Study Status

Record Verification Date
June 2019
Overall Recruitment Status
Unknown status
Study Start Date
May 28, 2018 (Actual)
Primary Completion Date
October 2019 (Anticipated)
Study Completion Date
November 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Indocyanine green is a fluorescent dye used for the intraoperative evaluation of tissue perfusion. The aim of this study is to evaluate a possible correlation between rectosigmoid vascularization and surgical and clinical data including pre and post-operative bowel symptoms in patients needing surgery for rectosigmoid endometriosis.
Detailed Description
Patients with symptomatic rectosigmoid endometriosis requiring laparoscopic surgery are included in the study. Before surgery, bowel symptoms are assessed using validated questionnaires (Knowles-Eccersley-Scott-Symptom Questionnaire and Gastrointestinal Quality of Life Index). Indocyanine green is administered through peripheral line. A near-infrared (NIR) camera-head enables real-time direct visualization of bowel perfusion before and after the removal of the rectosigmoid nodule. Rectosigmoid tract perfusion is assessed before and after the removal of the nodule. To estimate the vascularization, a scale with a score between 0 and 4 is used. After complete removal of rectosigmoid nodule, the post-operative follow-up will be the same as usual after intestinal endometriosis surgery. Postoperative bowel symptoms are evaluated using the same questionnaires.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Endometriosis, Rectum, Bowel Endometriosis

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Masking Description
OPEN
Allocation
Non-Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
laparoscopic approach
Arm Type
Other
Arm Description
assessment of bowel symptoms before surgery; assessment of rectosigmoid perfusion using indocyanine green; removal of rectosigmoid endometriosis nodule using a laparoscopic approach; follow up and assessment of bowel symptoms after surgery
Arm Title
robot-assisted approach
Arm Type
Other
Arm Description
assessment of bowel symptoms before surgery; assessment of rectosigmoid perfusion using indocyanine green; removal of rectosigmoid endometriosis nodule using a robot-assisted approach; follow up and assessment of bowel symptoms after surgery
Intervention Type
Diagnostic Test
Intervention Name(s)
assessment of bowel symptoms before surgery
Intervention Description
validated questionnaires (Knowles-Eccersley-Scott-Symptom Questionnaire and Gastrointestinal Quality of Life Index) are filled in by patients with rectosigmoid endometriosis before surgery
Intervention Type
Diagnostic Test
Intervention Name(s)
assessment of rectosigmoid during laparoscopy
Intervention Description
indocyanine green (0.25 mg/kg) is administered through peripheral line. A near-infrared camera-head (KARL STORZ Gesellschaft mit beschränkter Haftung & Co., Tuttlingen, Germany) is used to visualize bowel perfusion before and after the removal of the rectosigmoid nodule. To estimate the vascularization, a scale with a score between 0 and 4 is used
Intervention Type
Diagnostic Test
Intervention Name(s)
follow up and assessment of bowel symptoms after surgery
Intervention Description
validated questionnaires (Knowles-Eccersley-Scott-Symptom Questionnaire and Gastrointestinal Quality of Life Index) are filled in by patients with rectosigmoid endometriosis after surgery
Intervention Type
Diagnostic Test
Intervention Name(s)
assessment of rectosigmoid perfusion during robot-assisted laparoscopy
Intervention Description
indocyanine green (0.25 mg/kg) is administered through peripheral line. The robotic Firefly imaging system (daVinciXi surgical platform; Intuitive Surgical, Sunnyvale, CA) is used to visualize bowel perfusion before and after the removal of the rectosigmoid nodule. To estimate the vascularization, a scale with a score between 0 and 4 is used
Primary Outcome Measure Information:
Title
correlation between bowel symptoms and rectosigmoid perfusion before the nodule removal
Description
comparison between bowel symptoms, assessed through validated questionnaires (Knowles-Eccersley-Scott-Symptom Questionnaire and Gastrointestinal Quality of Life Index) and rectosigmoid perfusion, measured before the nodule removal using indocyanine green and a scale from 0 to 4.
Time Frame
intraoperative
Secondary Outcome Measure Information:
Title
correlation between bowel symptoms and rectosigmoid perfusion after the nodule removal
Description
comparison between rectosigmoid perfusion, measured after the nodule removal using indocyanine green and a scale from 0 to 4, and bowel symptoms, assessed through validated questionnaires (Knowles-Eccersley-Scott-Symptom Questionnaire and Gastrointestinal Quality of Life Index).
Time Frame
up to three months after surgery
Title
correlation between bowel perfusion after rectal surgery and post-operative complications
Description
assessment of rectosigmoid perfusion, through indocyanine green and a scale from 0 to 4, and complications (rectovaginal fistula, dehiscence of anastomotic suture, rectal bleeding, rectosigmoid perforation, rectosigmoid stenosis), using Clavien-Dindo Classification.
Time Frame
up to three months after surgery; from date of surgery until the date of first documented complication, assessed up to 3 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of deep endometriosis based on clinical and transvaginal/transabdominal ultrasound examinations and, when necessary, magnetic resonance Patients with indication for removal of endometriosic lesions by laparoscopic surgery Obtaining Informed Consent Exclusion Criteria: Known or suspected allergy to iodine Previous rectal surgery History of active pelvic infection Intra-abdominal or pelvic malignancy Pelvic radiation therapy Hyperthyroidism Liver dysfunction Serum creatinine > 2.0 mg/dL
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
DIEGO RAIMONDO
Phone
00390512144385
Email
DIE.RAIMONDO@GMAIL.COM
Facility Information:
Facility Name
Gynecology and Physiopathology of Human Reproductive Unit, University of Bologna, S. Orsola-Malpighi Hospital
City
Bologna
ZIP/Postal Code
40138
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Diego Raimondo
Phone
00390512144385
Email
die.raimondo@gmail.com
First Name & Middle Initial & Last Name & Degree
Mohamed Mabrouk
First Name & Middle Initial & Last Name & Degree
Renato Seracchioli
First Name & Middle Initial & Last Name & Degree
Diego Raimondo
First Name & Middle Initial & Last Name & Degree
Alessandro Arena
First Name & Middle Initial & Last Name & Degree
Raffaella Iodice
First Name & Middle Initial & Last Name & Degree
Manuela Mastronardi

12. IPD Sharing Statement

Learn more about this trial

Indocyanine Green and Rectosigmoid Endometriosis

We'll reach out to this number within 24 hrs